PUBLICATIONS
Articles
MCDA Hemlibra® in haemophilia A without inhibitors
Determining the value contribution of emicizumab (hemlibra®) for the prophylaxis of haemophilia A patients without inhibitors in Spain by multi-criteria decision analysis (MCDA) Avalia [...]
MCDA inhaler device in COPD treatment
Is patients’ perspective incorporated when choosing an inhaler device for COPD treatment? A framework value assessment based in Multi Criteria Decision Analysis Avaliable at: https://e [...]
MCDA framework for Oncologic Treatments
Development of a Multicriteria Decision Analysis Framework for Evaluating and Positioning Oncologic Treatments in Clinical Practice Avaliable at: https://ascopubs.org/doi/abs/10.1200/J [...]
MCDA Hemlibra® in haemophilia A with inhibitors
Determining the value contribution of emicizumab (Hemlibra®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis Avaliable at: https://jou [...]
MCDA framework for Ophan Drugs in Spain
Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain Avaliable at: https://www.tandfonline.com/doi/abs/10.1080/21678707.2019.1652 [...]
Analysis of Orphan Drugs P&R criteria in Spain (2012-2018)
Analysing criteria for price and reimbursement of orphan drugs in Spain Avaliable at: http://www.aulamedica.es/fh/pdf/11147.pdf [...]